En Es
Categories

Alere

Develops rapid point-of-care diagnostics that focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health.
Products NewsSummary
Close

News of Alere

Global Lateral Flow Assay Market to Exceed 8 Billion by 2022

08 Sep 2017
Global Lateral Flow Assay Market to Exceed 8 Billion by 2022
The global lateral flow assay market is projected to grow at a CAGR of 8.2% from USD 5.55 billion in 2017 to USD 8.24 billion by 2022, driven mainly by the high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care (POC) testing, and rising use of home-based lateral flow assay devices. These are the latest findings of Research and Markets, a global market research company.
Read More
Close

About Alere

Year of Establishment: 1981
Develops rapid point-of-care diagnostics that focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health.
FaceBook Twitter Google+ Linked in
Cholesterol Analyzer

Cholesterol Analyzer

Model: Alere Cholestech LDX
Request Information

Description:

The Alere Cholestech LDX is a CLIA-waived point-of-care analyzer for lipid profile, cholesterol, and glucose testing with unique safeguards, automated checks and calibrations to ensure accurate results and eliminate user error. Its rapid results provide immediate awareness and identification of cardiovascular and diabetes health risks in only five minutes using fingerstick sampling and a small sample size (40μL).


Send A Message To This Supplier

* Required Information
* Email
To
Alere (Cholesterol Analyzer)
* Message

Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions